DiamiR's Grant

DiamiR raised a round of funding on July 14, 2014. Investors include The Michael J. Fox Foundation.

DiamiR is a privately held molecular diagnostic company focused on developing noninvasive tests for early detection and monitoring of Mild Cognitive Impairment, Alzheimer's disease, other neurodegener…

Articles about DiamiR's Grant: